Greenwich LifeSciences extends insider lock-up to Jan. 31, 2027
GLSI•Board extends insider lock-up through Jan. 31, 2027
Greenwich LifeSciences’ board extended the share lock-up for directors, officers, and certain pre-IPO investors to Jan. 31, 2027.
The restriction keeps a 100% lock-up in place, barring sales unless the board modifies the terms.
Post-lock-up sales would shift to a leak-out plan with daily and period limits, unless the board changes the framework.
The board retained flexibility to end all or part of the lock-up early or adopt a leak-out plan or 10b5-1 selling program.
